Trials / Completed
CompletedNCT02262533
Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects
Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of Atenolol 100 mg on the Pharmacokinetics (PK) of Apixaban and the effect of Apixaban 10 mg on the PK of Atenolol in Healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apixaban | |
| DRUG | Atenolol |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2014-10-13
- Last updated
- 2015-08-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02262533. Inclusion in this directory is not an endorsement.